Drug price forecast estimates 3.29% increase in hospital drug spending for 2021

Health systems, together with inpatient and non-acute environments, can expect a 3.29% enhance for pharmaceutical buys designed from Jan. one to Dec. 31, 2021, in accordance to Vizient’s July 2020 Drug Value Forecast. The enhance will be pushed by both of those the ongoing disruption triggered by COVID-19 and enduring sector developments unrelated to the virus.

There has been uncertainty in many aspects of drug utilization in the course of the COVID-19 pandemic. But upward marketplace trends such as incredibly substantial prices for novel solutions (like gene therapies and immunotherapy for most cancers) and routine cost improves for regularly recommended

Read More

CMS announces two payment initiatives for COVID-19 drug treatment and counseling

The Centers for Medicare and Medicaid Solutions has declared two payment initiatives to monitor the performance of COVID-19 therapeutics and to use counseling to assist halt the distribute of the virus.

CMS will make payment obtainable to doctors and vendors to counsel patients at the time of COVID-19 testing about the worth of self-isolation immediately after they are tested and prior to the onset of symptoms. 

CMS will use current analysis and administration payment codes to reimburse vendors who are suitable to monthly bill CMS for counseling solutions, no issue exactly where a examination is administered, regardless of whether it

Read More

Trump’s proposed executive orders on drug pricing may hinder R&D and drug development

Lately, President Trump proposed four unique executive orders aimed at lowering drug selling prices in a transfer that some see as calculated to safe votes from seniors in the run-up to November’s presidential election. You will find no doubt that drug selling prices have turn out to be a problem for numerous Individuals, but as finer information of the executive orders have still to emerge, it truly is unclear regardless of whether they would have the supposed impact if enacted.

The broad strokes are there. A single proposed executive get would reduce rebates from drug organizations that go to pharmacy

Read More

CMS proposes value-based purchasing rule to lower drug prices and increase availability

The Facilities for Medicare and Medicaid Solutions yesterday issued a proposed rule to get started eliminating boundaries to the progress of price-primarily based payment agreements in between drug makers and payers, together with Medicaid.

The rule would also propose modifications to existing laws dealing with how makers establish the rate of manufacturer identify medicines when there is an approved generic version also on the market place.

In addition, it proposes bare minimum standards in condition Medicaid Drug Utilization Evaluate packages designed to lower opioid-similar fraud, misuse, and abuse.

WHY IT Issues

Underneath existing laws, payers and makers generally foundation their

Read More

SEC Questions COVID Drug Claims of Biotechs

The U.S. Securities and Exchange Fee has briefly halted buying and selling in the shares of three biotech organizations for the reason that of problems above the precision of statements they have produced about a drug candidate for treating COVID-19.

Houston-primarily based CNS Pharmaceuticals and WPD Pharmaceuticals of Vancouver, B.C., have stated they are creating a COVID-19 drug labeled WP1122, with Moleculin Biotech, also of Houston, as their license husband or wife.

The buying and selling suspensions are the SEC’s most up-to-date move “to crack down on untrue information concerning assessments, therapies or devices relating to the [coronavirus], which has

Read More